Delivery Order SPE2DB24D9238-SPE2DB25FDQTR
Award Date
4/28/25
Potential Completion Date
5/19/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,461.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to be delivered by July 15, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and there are no noted subcontractors. This order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,976.24 order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of September 25, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,028.88 award is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through March 25, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $7,461.66 order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that runs through December 31, 2025. This IDC allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,531.89 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $6,175.74 order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a performance period through May 6, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,711.28 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a ceiling value of $15,063.78 and an ultimate completion date of May 16, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors listed. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,510.63 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of...